Associated Papers
The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS.
Bansod S et al.
Cell Reports, 2024
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
Dodhiawala PB et al.
The Journal of Clinical Investigation, 2020
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Mao Y et al.
Plos One, 2013
24205039 (PubMed )
Supplement: pone.0077945.s001.xls › Table_S4
Select a paper to view details